Form 4 for BHC Bausch Health Companies Inc.
Accepted 2025-08-22 00:00:00 ET · period of report 2025-08-21 · accession 0001127602-25-020878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-22 | 2025-08-21 | BHC | Lee Frank D. | Dir | S - Sale | $7.66 | -15.9K | 73.8K | -18% | -$121.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2025-08-21 | S | D | 15,912 | $7.66 | 73,795 | D | — | — | (F1) Represents shares of common stock, no par value, of the Issuer sold in the open market to provide funds for estimated tax payments arising from a previously vested equity award granted to the Issuer's non-employee directors. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.66 to $7.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |